Skip to main content
. 2017 Dec 27;15(3):2815–2820. doi: 10.3892/ol.2017.7691

Figure 4.

Figure 4.

KPNA2 expression is negatively associated with patient overall and disease-free survival time. (A) Overall survival curve for patients with high and low KPNA2 expression. (B) Disease-free survival curve for patients with high and low KPNA2 expression. (C) Overall survival curve for patients with high and low CCNB2 expression. (D) Overall survival curve for patients with high and low CDK1 expression. All figure sections were generated using cBioportal. KPNA2, karyopherin-α; CNNB2, cyclin B2; CDK1, cyclin-dependent kinase 1.